← FDA Drug Approvals (Drugs@FDA)

MELOXICAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASCENT PHARMS INC · Approved 2023-06-07

Drug application

FDA Application #

ANDA217579

Application type

Abbreviated New Drug Application (Generic)

Brand name

MELOXICAM

Generic name

MELOXICAM

Active ingredients

MELOXICAM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ASCENT PHARMS INC

Manufacturer

XLCare Pharmaceuticals, Inc.

First approval

2023-06-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown